Trial Type: Other Digestive Organ

LS-P-CAPE
A Phase II, Open-label, Multi-centre Study to Evaluate Safety, Tolerability, Efficacy, PK, and Immunogenicity of AZD0901 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Tumours Expressing Claudin 18.2 (CLARITY-PanTumour01)
Protocol Status: OPEN TO ACCRUAL
Trial Type: Esophagus, Gastrointestinal, Other Digestive Organ, Pancreas, Stomach
Contact: Raufi, Alexander
araufi2@BrownHealth.org
BH-P-ARTEMIDE-BILIARY02
Phase III, Randomized, Open-label, Global, Multicenter Study of Rilvegostomig or Durvalumab in Combination With Chemotherapy as a First-line Treatment for Patients With Advanced Biliary Tract Cancer (ARTEMIDE-Biliary02)
Protocol Status: OPEN TO ACCRUAL
Trial Type: Gastrointestinal, Other Digestive Organ
Contact: Almhanna, Khaldoun
kalmhanna@BrownHealth.org
BRUOG-452
TLR9 Immunotherapy for Peritoneal Carcinomatosis (TIPC) – Phase 1 Study of the Safety and Efficacy of ACM-CpG Intraperitoneal Injections for Treatment in Patients With Colorectal or Appendiceal Adenocarcinoma Peritoneal Metastases or Malignant Ascites
Protocol Status: OPEN TO ACCRUAL
Trial Type: Colon, Gastrointestinal, Other Digestive Organ
Contact: Almhanna, Khaldoun
kalmhanna@BrownHealth.org